Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Bladder Cancer

Free Subscription 22.04.2019 1 Biomed Res Int 1 BMC Infect Dis 1 BMC Urol 1 Bull Cancer 1 Cancer Commun (Lond) 1 Cancer Immunol Res 1 Clin Adv Hematol Oncol 1 Clin Chem 1 Dis Markers 1 Endocr Connect 2 Eur Urol 1 Exp Cell Res 2 Exp Ther Med 1 FEBS Open Bio 1 Front Genet 1 Gene 1 J Exp Clin Cancer Res 1 J Food Drug Anal 1 J Magn Reson Imaging 1 J Oncol 1 J Oncol Pharm Pract 1 J Transl Int Med 1 Oncol Lett 1 Technol Cancer Res Treat 1 Urology 1 World J Urol 1 Zhonghua Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Biomed Res Int

1. LI M, Wang Y, Liu Y, Zhang X, et al
   Low Expression of hsa_circ_0018069 in Human Bladder Cancer and Its Clinical Significance.
   Biomed Res Int. 2019;2019:9681863.
   PubMed     Text format     Abstract available
   
   

   
   BMC Infect Dis

2. NGUYEN MH, Giordani MM, Thompson GR 3rd
   The double-edged sword - prosthetic joint infection following BCG treatment for bladder cancer: a case report.
   BMC Infect Dis. 2019;19:331.
   PubMed     Text format     Abstract available
   
   

   
   BMC Urol

3. WANG Q, Zhang T, Wu J, Wen J, et al
   Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
   BMC Urol. 2019;19:24.
   PubMed     Text format     Abstract available
   
   

   
   Bull Cancer

4. HOUEDE N, Milano G
   [Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine].
   Bull Cancer. 2019 Apr 10. pii: S0007-4551(19)30146.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Commun (Lond)

5. LI Z, Liu Z, Yao K, Qin Z, et al
   An improved ileal conduit surgery for bladder cancer with fewer complications.
   Cancer Commun (Lond). 2019;39:19.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Immunol Res

6. PFANNSTIEL C, Strissel PL, Chiappinelli KB, Sikic D, et al
   The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes.
   Cancer Immunol Res. 2019 Apr 15. pii: 2326-6066.CIR-18-0758.
   PubMed     Text format     Abstract available
   
   

   
   Clin Adv Hematol Oncol

7. ROUVINOV K, Plimack ER, Zibelman M, Ghatalia P, et al
   Update on perioperative systemic therapy for urothelial carcinoma.
   Clin Adv Hematol Oncol. 2019;17:176-183.
   PubMed     Text format     Abstract available
   
   

   
   Clin Chem

8. CHENG THT, Jiang P, Teoh JYC, Heung MMS, et al
   Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
   Clin Chem. 2019 Apr 15. pii: clinchem.2018.301341.
   PubMed     Text format     Abstract available
   
   

   
   Dis Markers

9. YANG L, Li YL, Li XQ, Zhang Z, et al
   High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer.
   Dis Markers. 2019;2019:4586405.
   PubMed     Text format     Abstract available
   
   

   
   Endocr Connect

10. SZARVAS T, Jardin-Watelet B, Bourgoin N, Hoffmann MJ, et al
    High soluble CGA levels are associated with poor survival in bladder cancer.
    Endocr Connect. 2019 Apr 1. pii: EC-19-0068.R1. doi: 10.1530/EC-19-0068.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol

11. SORIA F, Gontero P
    Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    Eur Urol. 2019 Apr 12. pii: S0302-2838(19)30275.
    PubMed     Text format    
    
    
12. SAITA A, Lughezzani G, Buffi NM, Hurle R, et al
    Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging.
    Eur Urol. 2019 Apr 10. pii: S0302-2838(19)30277.
    PubMed     Text format     Abstract available
    
    

    
    Exp Cell Res

13. ZHUO D, Wu Y, Luo J, Deng L, et al
    CSTP1 inhibits IL-6 expression through targeting Akt/FoxO3a signaling pathway in bladder cancer cells.
    Exp Cell Res. 2019 Apr 16. pii: S0014-4827(19)30193.
    PubMed     Text format     Abstract available
    
    

    
    Exp Ther Med

14. HSIAO CH, Yao CJ, Lai GM, Lee LM, et al
    Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells.
    Exp Ther Med. 2019;17:4213-4222.
    PubMed     Text format     Abstract available
    
    
15. WU X, Chen B, Shi H, Zhou J, et al
    miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.
    Exp Ther Med. 2019;17:4273-4278.
    PubMed     Text format     Abstract available
    
    

    
    FEBS Open Bio

16. DING B, Yan L, Zhang Y, Wang Z, et al
    Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
    FEBS Open Bio. 2019;9:693-706.
    PubMed     Text format     Abstract available
    
    

    
    Front Genet

17. LI Y, Shi B, Dong F, Zhu X, et al
    Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis.
    Front Genet. 2019;10:280.
    PubMed     Text format     Abstract available
    
    

    
    Gene

18. ZHANG Q, Mao Z, Sun J
    NF-kappaB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-kappaB/Snail signaling in bladder cancer cells.
    Gene. 2019 Apr 16. pii: S0378-1119(19)30392-0. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available
    
    

    
    J Exp Clin Cancer Res

19. MAO W, Huang X, Wang L, Zhang Z, et al
    Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
    J Exp Clin Cancer Res. 2019;38:169.
    PubMed     Text format     Abstract available
    
    

    
    J Food Drug Anal

20. CHEN YT, Huang HC, Hsieh YJ, Fu SH, et al
    Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
    J Food Drug Anal. 2019;27:460-474.
    PubMed     Text format     Abstract available
    
    

    
    J Magn Reson Imaging

21. XU X, Wang H, Du P, Zhang F, et al
    A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
    J Magn Reson Imaging. 2019 Apr 13. doi: 10.1002/jmri.26749.
    PubMed     Text format     Abstract available
    
    

    
    J Oncol

22. LIU Y, Lu J, Huang Y, Ma L, et al
    Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guerin for Bladder Cancer.
    J Oncol. 2019;2019:6230409.
    PubMed     Text format     Abstract available
    
    

    
    J Oncol Pharm Pract

23. HANNA KS
    Updates and novel treatments in urothelial carcinoma.
    J Oncol Pharm Pract. 2019;25:648-656.
    PubMed     Text format     Abstract available
    
    

    
    J Transl Int Med

24. ZACHOS I, Zachou K, Dalekos GN, Tzortzis V, et al
    Management of Patients with Liver Cirrhosis and Invasive Bladder Cancer: A Case-series.
    J Transl Int Med. 2019;7:29-33.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Lett

25. XIANG M, Yuan W, Zhang W, Huang J, et al
    Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells.
    Oncol Lett. 2019;17:4437-4442.
    PubMed     Text format     Abstract available
    
    

    
    Technol Cancer Res Treat

26. HUANG Y, Cen J, Liu Z, Wei J, et al
    A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
    Technol Cancer Res Treat. 2019;18:1533033819844483.
    PubMed     Text format     Abstract available
    
    

    
    Urology

27. LORENZO SORIANO L, Ordaz Jurado G, Pontones Moreno JL, Villarroya Castillo S, et al
    TUMOR BUDDING: PROGNOSTIC VALUE IN MUSCLE-INVASIVE BLADDER CANCER.
    Urology. 2019 Apr 12. pii: S0090-4295(19)30344.
    PubMed     Text format     Abstract available
    
    

    
    World J Urol

28. FERRO M, Di Lorenzo G, Vartolomei MD, Bruzzese D, et al
    Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor.
    World J Urol. 2019 Apr 16. pii: 10.1007/s00345-019-02754.
    PubMed     Text format     Abstract available
    
    

    
    Zhonghua Yi Xue Za Zhi

29. YANG FY, Wang WK, Liu S, Song LM, et al
    [Clinical experiences of laparoscopic radical cystectomy and urinary diversion in the elderly patients with bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2019;99:1101-1105.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: